INTRODUCTION

AGIVOG 0.3MG contain Voglibose which belongs to a group of medicine called competitive α glucosisade inhibitors (α-GIs). It is indicated to improve postprandial hyperglycaemia in patients with type 2 diabetes mellitus. Type 2 diabetes mellitus is a condition in which your body does not make enough insulin, and or the insulin produces does not work. When this happens, your body makes too much of sugar (i.e. glucose) which gets build up in the blood resulting in serious health problems.

AGIVOG 0.3MG works by inhibiting the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meal. The most common side effects are diarrhoea, nausea, vomiting, dizziness, constipation, heartburn. This medicine must be taken at start of a meal and try to take at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine.

Your blood sugar will be monitored by your periodically, with regular blood test, including your blood sugar level and your hemoglobin A1C. Stay on exercise and diet as prescribed by your doctor while taking this medicine. Before taking this medicine tell your doctor if you have ever had kidney disease, heart disease, or pancreas problems. Pregnant or breastfeeding women should consult their doctor before taking AGIVOG 0.3MG.

USES OF AGIVOG 0.3MG

• Helps to improve postprandial hyperglycaemia in patients with type 2 diabetes mellitus

HOW AGIVOG 0.3MG WORKS

It works by inhibiting the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.

DIRECTIONS FOR USE

Always take AGIVOG 0.3MG exactly as your doctor has told you. This medicine must be taken start of a meal. Try to take AGIVOG 0.3MG at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine.

SIDE EFFECTS OF AGIVOG 0.3MG

HOW TO MANAGE SIDE EFFECTS

Diarrhoea:

Drink lot of fluid such as water or squash, to avoid dehydration. Do not take any other medicine without talking to a doctor.

Nausea and vomiting:

Try taking this medicine with, or just after, a meal or snack and stick to simple meals and do not eat rich or spicy food.

Dizziness:

Get up and move around to feel awake, take small naps to edge off the sleepiness. Give your eyes a break to avoid fatigue and eat a healthy food to boost energy. 

Constipation:

Take fibre rich foods such as fresh fruit, vegetables and cereals, and drink plenty of water. Exercise more regularly.

WARNING & PRECAUTIONS

INTERACTIONS

Talk to your doctor if you are taking,

• antidiabetic medicines such as sulfonylamide and sulfonylarea, bigluconide derivatives, insulin preparations and agents (used for improving insulin resistance)
• beta blockers, salicylates, MAO inhibitors and fibrates (Helps to enhance the hypoglycaemic action)
• epinephrine, adrenocortical hormone, and thyroid hormones (Helps to reduce hypoglycaemic action)
• warfarin

SYNOPSIS

MORE INFORMATION

Store at room temperature and keep out of reach of children.

FAQs ABOUT AGIVOG 0.3MG

How does AGIVOG 0.3MG works?

It works by inhibiting the intestinal enzymes responsible for breaking complex sugars into simple sugars such as glucose. This prevents blood glucose levels from rising very high immediately after meals.

Can I take AGIVOG 0.3MG during pregnancy?

It should be used with caution in pregnant women. Consult your doctor before taking.

Can AGIVOG 0.3MG cause Constipation?

Yes, this medicine may cause constipation in some individuals. Take fibre rich foods such as fresh fruit, vegetables and cereals, and drink plenty of water. Exercise more regularly.

REFERENCES

1. KD Tripathi. Insulin, Oral Hypoglycaemic Drugs and Glucagon. Essentials of Medical Pharmacology. seventh edition.2013. Page-277.

2. Bertram G. Katzung, Pancreatic Hormones and Antidiabetic Drugs, Basic & Clinical Pharmacology, Fourteenth Edition, 2015. Page-761.

3. Ajay S. Dabhi,1 Nikita R. Bhatt,2 and Mohit J. Shah3. Voglibose: An Alpha Glucosidase Inhibitor.US National Library of Medicines, National Institutes of Health. 15 Dec 2013. [Accessed 30 Oct 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/#:~:text=So%20voglibose%3A,carbohydrate%20absorption%20and%20decreases%20PPHG

4. Ajay S Dabhi 1, Nikita R Bhatt 2, Mohit J Shah 3. Voglibose: an alpha glucosidase inhibitor. NIH: National Library of Medicine, National center of biotechnology Information Pubmed.gov. Dec 2013. [Accessed 30 Oct 2020] https://pubmed.ncbi.nlm.nih.gov/24551718/

5. Cipla med, August 2015 [Revised on August 2015] [Accessed 30 Oct 2020] https://www.ciplamed.com/content/prandial-md-tablets

USEFUL DIAGNOSTIC TESTS

• Glucose - Fasting Blood
• Glucose - Postprandial Blood
• Glycosylated Hemoglobin